Lymphoma Trial, Recruiting NCT06796517 Sponsor: Sung-Soo Park Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT06796517
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between the ages of 19 and 74 years old
  • People who have been diagnosed after January 2015 with one of these blood cancers: diffuse large B cell lymphoma, primary mediastinal large B cell lymphoma, high grade B cell lymphoma, or Burkitt lymphoma
  • People who have received a combination of immune therapy and chemotherapy to treat lymphoma that came back or stopped responding to earlier treatment

Who may not be able to join:

  • People whose condition has progressed into a form of blood cancer called acute leukemia
  • People who developed a solid tumour (a growth in body tissue) during their treatment
  • People who currently have an active infection, such as acute pneumonia, a viral infection, active hepatitis B, or active tuberculosis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +82-02-2258-6754

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sung-Soo Park
Registry
ClinicalTrials.gov
Start date
26 June 2024
Est. completion
1 December 2025

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Overall survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov